ExoVasc® PEARS

18 Year old undertakes PEARS procedure

Share:

A further patient received the ExoVasc® support in late September. For Professor John Pepper this successful operation on an 18-year old patient adds new data to the clinical trial. Results on the 12 – 48 month follow-up of the first group of patients in the trial are currently being analysed in preparation for the publication of a scientific paper.

Share:

Related articles

SME News, Managing Director of the Year Awards

Victoria Sharpe named as one of the Top 50 Women in Engineering 2024

Interested in our patient experiences?